FogPharma and Artbio, two buzzy biotechnology companies, are betting they can combine their respective technologies to design a new type...
Medicine
German pharmaceutical company Bayer eliminated 1,500 roles during the first three months of the year as part of a company...
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief:...
Takeda Pharmaceutical is betting potentially billions of dollars on drugs designed to slow Alzheimer’s disease by harnessing the immune system....
Medicines called JAK inhibitors are well known in the pharmaceutical industry. Several are approved to treat inflammatory disease conditions or...
Dive Brief: AstraZeneca will no longer manufacture or supply its COVID-19 vaccine Vaxzevria, announcing Tuesday it is voluntarily withdrawing the shot...
Dive Brief: Sanofi will pay vaccine maker Novavax $500 million and take a small equity stake in the Maryland-based company...
Dive Brief: Biotechnology startup Maze Therapeutics has licensed a Pompe disease drug to Shionogi, five months after a challenge from...
Moderna on Friday said the Food and Drug Administration has postponed an approval decision on its experimental vaccine for respiratory...
BioPharma Dive is testing out a new format rounding up smaller updates from around the industry. Have thoughts on what...